Hims & Hers Health, Inc. Class Action Lawsuit Filed, Lead Plaintiff Deadline August 25, 2025

Purchasers of Hims & Hers Health, Inc. common stock between April 29, 2025, and June 23, 2025, both dates inclusive, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lawsuit claims that defendants made false and misleading statements about the communication between Hims and the pharmaceutical company Novo Nordisk A/S, which would facilitate a long-term collaboration to ensure continued access to the weight-loss drug Wegovy for Hims subscribers.

Key Takeaways:

• The class action lawsuit was filed due to alleged false and misleading statements made by Hims & Hers Health, Inc. about the communication with Novo Nordisk A/S.
• The lawsuit claims that investors suffered damages when the true details entered the market.
• The lead plaintiff deadline is August 25, 2025, for investors who purchased Hims common stock during the Class Period.
• Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
• Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time.
• Over $438 million was secured for investors in 2019 alone by Rosen Law Firm.
• Laurence Rosen, founding partner of Rosen Law Firm, was named by law360 as a Titan of Plaintiffs' Bar in 2020.
• Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Statistics:

• The class action lawsuit was filed between April 29, 2025, and June 23, 2025, both dates inclusive.
• The lead plaintiff deadline is August 25, 2025.
• Rosen Law Firm secured over $438 million for investors in 2019.
• Laurence Rosen, founding partner of Rosen Law Firm, has been recognized by Law360 as a Titan of Plaintiffs' Bar.

Sources:

• Newsfile Corp.
• Rosen Law Firm
• Law360